Medical therapy of sarcoidosis: who to treat and how?

R. P. Baughman (Cincinnati, United States of America)

Source: Annual Congress 2012 - PG8 State-of-the-art management of sarcoidosis
Session: PG8 State-of-the-art management of sarcoidosis
Session type: Postgraduate Course
Number: 19

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. P. Baughman (Cincinnati, United States of America). Medical therapy of sarcoidosis: who to treat and how?. Annual Congress 2012 - PG8 State-of-the-art management of sarcoidosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Medical therapy for COPD: lessons from the real world
Source: Eur Respir J 2002; 20: 797-798
Year: 2002

Talk from Warsaw – When do we need to treat airway infection in COPD?
Source: ERS Satellites 2019
Year: 2019

What's new in sarcoidosis management?
Source: Annual Congress 2013 –ME5 What's new in sarcoidosis management?
Year: 2013



Interventional treatment of pulmonary hypertension: where are we now?
Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases
Year: 2020


Talk from Athens – Genetics: diagnosing, counseling, and optimising therapy in fibrotic lung diseases
Source: ERS Satellites 2019
Year: 2019

Education and information for patients with bronchiectasis: What do patients want?
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011

Pharmacotherapy of CSA: who, when and how?
Source: Sleep and Breathing Conference 2021
Year: 2021


Cancer treatment in pulmonary hypertension: cause or cure?
Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension
Year: 2013


Positional therapy: who, when and how?
Source: Sleep and Breathing Conference 2021
Year: 2021


Characterising asthma therapy in Scotland: Are the guidelines confusing?
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012


Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Antifungals in pulmonary infections: to whom, when and how?
Source: Eur Respir Monogr 2017; 75: 159-184
Year: 2017


Specific features of modern approach to management of patients with pulmonary sarcoidosis in Saint-Petersburg Sarcoidosis Center
Source: Eur Respir J 2007; 30: Suppl. 51, 84s
Year: 2007

Pulmonary rehabilitation: can we identify the patients who will benefit most?
Source: Eur Respir J 2001; 18: Suppl. 33, 187s
Year: 2001

How well can we practically apply asthma guidelines?
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


Medical thoracoscopy: how do I do it?
Source: Annual Congress 2012 - PG1 Interventional pulmonology procedures: best practice
Year: 2012



Paediatric asthma: where to go?
Source: Eur Respir Rev 2012 21:173-174
Year: 2012